Functional Medicine for Chronic Fatigue: Beyond Tired

ByRohan Smith
Functional Medicine for Chronic Fatigue: When Just Tired Is Something More

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Persistent fatigue unrelieved by rest may indicate myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or post-viral fatigue such as long COVID. These conditions are associated with post-exertional malaise, mitochondrial dysfunction, immune dysregulation, and neuroinflammation. A functional medicine approach aims to identify these underlying biological contributors through personalised, systems-based assessment rather than symptom suppression alone (1-4).

At a Glance

  • ME/CFS affects an estimated 0.4-1% of the population and is defined by the Institute of Medicine (now National Academy of Medicine) as a systemic neuroimmune condition (1).
  • Long COVID and ME/CFS may share overlapping mechanisms including impaired oxidative phosphorylation, cytokine dysregulation, and autonomic dysfunction (3,4).
  • Post-exertional malaise (PEM) distinguishes ME/CFS from ordinary fatigue, with symptom flares lasting 24-72 hours or longer after minimal exertion (6).
  • Cellular bioenergetics research by Tomas et al. (2017) demonstrated impaired mitochondrial respiration in ME/CFS patient lymphocytes compared to healthy controls (8).
  • Standard blood panels may not capture mitochondrial efficiency, diurnal cortisol patterns, or inflammatory cytokine signatures associated with chronic fatigue states (15).

Persistent Fatigue Signals Systemic Dysfunction, Not Lifestyle Weakness

Approximately 836,000 to 2.5 million Americans may have ME/CFS according to the National Academy of Medicine (formerly the Institute of Medicine), with similar prevalence patterns observed in Australia (1). When exhaustion persists for months, worsens after minimal exertion, and interferes with daily function, it suggests a systemic issue rather than simple overwork.

Many people describe waking already exhausted, experiencing “crashes” after minor activity, or never feeling restored by sleep. These features are characteristic of ME/CFS, which is defined by prolonged fatigue, post-exertional malaise, unrefreshing sleep, and cognitive impairment (1,2). A broader overview of how this is approached clinically is outlined in our chronic fatigue functional medicine guide.

A similar pattern is now widely observed following SARS-CoV-2 infection. Long COVID frequently includes persistent fatigue, neurological symptoms, and exercise intolerance months after the acute illness, with significant biological overlap with ME/CFS (3-5). Nath (2020) noted in Neurology that post-infectious fatigue syndromes following COVID-19 may mirror the neuroimmune dysfunction seen in established ME/CFS cases (5).

ME/CFS and Long COVID Share Measurable Biological Patterns

Komaroff and Lipkin (2021) identified convergent pathophysiology between post-COVID fatigue and ME/CFS, including overlapping immune, metabolic, and neurological abnormalities (4). Research increasingly demonstrates measurable physiological changes affecting energy production, immune regulation, and nervous system signalling.

Post-Exertional Malaise (PEM)

Post-exertional malaise refers to a delayed and disproportionate worsening of symptoms following physical, cognitive, or emotional effort. VanNess et al. (2007) documented that recovery from PEM episodes may take days or weeks, reflecting impaired energy metabolism and abnormal hypothalamic-pituitary-adrenal (HPA) axis stress responses (1,6).

Mitochondrial Dysfunction

Mitochondria generate cellular energy through oxidative phosphorylation via the electron transport chain and the citric acid cycle (Krebs cycle). Tomas et al. (2017) demonstrated impaired mitochondrial respiration in peripheral blood mononuclear cells of ME/CFS patients, with reduced ATP-linked respiration and reserve capacity (8). Myhill, Booth, and McLaren-Howard (2009) further reported that ATP profiles correlated with ME/CFS symptom severity (9). Functional assessment of these pathways may involve specialised tools such as mitochondrial function testing.

Immune Dysregulation and Chronic Inflammation

Montoya et al. (2017) identified a cytokine signature in ME/CFS patients correlated with disease severity, with 17 cytokines showing dose-response relationships at higher symptom levels (10). Many individuals with ME/CFS or long COVID show signs of persistent immune activation, altered T-cell and natural killer (NK) cell function, and reduced immune tolerance following infection or environmental stressors (4,10,11). Rasa et al. (2018) reviewed evidence linking chronic viral reactivation, including Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6), to ongoing immune dysregulation in ME/CFS (11). Ongoing immune activation can also influence mood and cognition, which is explored further in our mental health and neuroinflammation resource.

Neuroinflammation and Autonomic Dysfunction

Perrin et al. (2018) proposed that brainstem dysfunction may contribute to autonomic imbalance in ME/CFS, affecting cardiovascular and sleep regulation (14). Dysautonomia, including postural orthostatic tachycardia syndrome (POTS), is commonly reported in both ME/CFS and long COVID, as documented by Raj et al. (2018) showing significant clinical overlap between the two conditions (12-14).

Standard Medical Testing Often Misses Functional Imbalances

Conventional pathology panels are designed to detect overt disease states such as anaemia or thyroid failure, rather than subtle system-level dysfunction in mitochondrial efficiency, cytokine signalling, or neuroendocrine rhythm disruption (6,15). Cleare (2003) demonstrated in Endocrine Reviews that HPA axis abnormalities in ME/CFS are typically subtle and not captured by standard cortisol assays (15).

Functional Medicine Testing Evaluates Patterns Across Interconnected Systems

A functional medicine approach does not rely on a single abnormal marker. Instead, it evaluates trends, relationships, and physiological balance across interconnected systems. Depending on clinical history, assessment may include:

Assessment Domain What Is Evaluated Relevance to Chronic Fatigue
Inflammatory markers hs-CRP, cytokine panels, albumin-to-globulin ratio May reveal persistent low-grade immune activation
Micronutrient status B vitamins (B12, folate, B6), magnesium, zinc, CoQ10, iron studies Cofactors required for mitochondrial enzyme function and ATP synthesis
Immune cell differentials Lymphocyte subsets, NK cell counts assessed longitudinally May indicate chronic immune activation or suppression patterns
Adrenal and hormone rhythms Diurnal cortisol, DHEA-S, melatonin via DUTCH adrenal testing HPA axis dysregulation commonly associated with ME/CFS (15)
Metabolic by-products Organic acids, lactate-to-pyruvate ratio, amino acid profiles May reflect impaired oxidative phosphorylation and Krebs cycle function

These findings help explain why symptoms persist and guide individualised care planning rather than symptom suppression.

Recovery Requires a Systems-Based Framework Addressing Multiple Pathways

Effective care for chronic fatigue typically addresses multiple physiological systems while respecting individual tolerance and recovery capacity, rather than relying on a single intervention.

Energy Metabolism Support

Nutrients involved in mitochondrial enzyme activity and cellular energy transfer, including coenzyme Q10 (CoQ10), nicotinamide adenine dinucleotide (NADH), D-ribose, and magnesium, may be considered when deficiencies or increased metabolic demand are identified (7,8).

Immune and Inflammatory Regulation

Reducing inappropriate immune activation and oxidative stress through targeted antioxidant support and immune-modulating strategies is often central to symptom improvement, particularly in post-viral fatigue states (4,10).

Restoring Hormonal and Circadian Rhythms

Disrupted cortisol rhythms and autonomic imbalance can perpetuate fatigue and sleep disturbance. Gradual rhythm restoration, rather than forced stimulation, is a core principle of care. This may involve melatonin timing, adaptogenic herbs, and light-dark cycle optimisation (12,15).

These strategies are not universal protocols and require individual assessment, pacing, and ongoing adjustment.

Frequently Asked Questions

How is chronic fatigue different from being “burnt out” or overworked?
Burnout typically improves with rest, time off, and stress reduction. Chronic fatigue states such as ME/CFS or post-viral fatigue persist despite rest and are often characterised by post-exertional malaise (PEM), unrefreshing sleep, and cognitive impairment. These features suggest underlying biological dysfunction rather than simple lifestyle exhaustion.

Can exercise help with chronic fatigue?
Exercise tolerance varies significantly. In individuals with post-exertional malaise, pushing through fatigue can worsen symptoms and delay recovery. A functional approach prioritises pacing, energy management, and stabilisation of physiological systems before considering any graded physical activity.

Is functional medicine claiming to cure chronic fatigue?
No. Functional medicine does not promise cures. Its role is to identify contributing biological factors — such as immune dysregulation, mitochondrial stress, or hormonal rhythm disruption — and support these systems in a personalised way. Outcomes vary, and care is focused on improving function and quality of life rather than guaranteeing recovery.

Key Insights

  • Chronic fatigue and long COVID reflect measurable biological dysfunction, not lifestyle weakness
  • Post-exertional malaise, mitochondrial dysfunction, and immune dysregulation are central mechanisms
  • Standard blood tests often miss the subtle system-level patterns driving persistent fatigue
  • Functional testing evaluates trends and relationships across interconnected physiological systems

Citable Takeaways

  1. The Institute of Medicine (now National Academy of Medicine) redefined ME/CFS in 2015 as a systemic neuroimmune condition characterised by post-exertional malaise, unrefreshing sleep, and cognitive impairment, estimating that 836,000 to 2.5 million Americans may be affected (1).
  2. Tomas et al. (2017) demonstrated that peripheral blood mononuclear cells from ME/CFS patients exhibited significantly impaired mitochondrial respiration, including reduced ATP-linked respiration and reserve capacity, compared to healthy controls (8).
  3. Montoya et al. (2017) identified 17 cytokines whose plasma concentrations correlated with ME/CFS symptom severity in a dose-response pattern, suggesting persistent immune activation as a measurable feature of the condition (10).
  4. Komaroff and Lipkin (2021) documented convergent pathophysiology between long COVID and ME/CFS, including overlapping immune dysregulation, metabolic impairment, and autonomic dysfunction (4).
  5. Cleare (2003) reported in Endocrine Reviews that HPA axis abnormalities in ME/CFS, including blunted cortisol responses, are typically too subtle to detect with standard single-point cortisol assays (15).
  6. Raj et al. (2018) documented significant clinical overlap between postural orthostatic tachycardia syndrome (POTS) and ME/CFS, with autonomic dysfunction contributing to exercise intolerance and fatigue in both conditions (12).

Living With Chronic Fatigue That Standard Tests Cannot Explain?

If persistent fatigue, post-viral symptoms, or unexplained exhaustion are limiting your daily life, a functional medicine approach may help uncover what standard testing overlooks. At Elemental Health and Nutrition, we investigate immune, mitochondrial, and hormonal contributors to chronic fatigue through personalised, systems-based assessment.

Book an Appointment

References

  1. Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Press; 2015. https://doi.org/10.17226/19012
  2. Jason LA et al. Myalgic encephalomyelitis/chronic fatigue syndrome: symptoms and biomarkers. Front Pediatr. 2018 Oct 29;6:242. https://doi.org/10.3389/fped.2018.00242
  3. Davis HE et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019
  4. Komaroff AL et al. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne). 2021 Jan 18;7:606824. https://doi.org/10.3389/fmed.2020.606824
  5. Nath A. Long-Haul COVID. Neurology. 2020 Dec 15;95(24):1091-1092. https://doi.org/10.1212/WNL.0000000000011062
  6. VanNess JM et al. Postexertional malaise in chronic fatigue syndrome. J Chronic Fatigue Syndr. 2007;14(2):3-14. https://doi.org/10.1300/J092v14n02_02
  7. Missailidis D et al. An attempt to explain the neurological symptoms of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. 2021 Dec 6;10(23):5588. https://doi.org/10.3390/jcm10235588
  8. Tomas C et al. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS One. 2017 Oct 24;12(10):e0186802. https://doi.org/10.1371/journal.pone.0186802
  9. Myhill S et al. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2(1):1-16. https://pubmed.ncbi.nlm.nih.gov/19430687
  10. Montoya JG et al. Cytokine signature associated with disease severity in ME/CFS patients. Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E7150-E7158. https://doi.org/10.1073/pnas.1710519114
  11. Rasa S et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2018 Jun 1;16(1):162. https://doi.org/10.1186/s12967-018-1542-1
  12. Raj SR et al. Postural orthostatic tachycardia syndrome (POTS) and chronic fatigue syndrome (CFS): overlapping entities? Auton Neurosci. 2018 Mar;215:1-6. https://doi.org/10.1016/j.autneu.2017.11.001
  13. Newton JL et al. The Newcastle model: a model for the investigation of chronic fatigue syndrome. QJM. 2007 Jul;100(7):429-36. https://doi.org/10.1093/qjmed/hcm042
  14. Perrin R et al. Brainstem dysfunction in chronic fatigue syndrome: a role for the autonomic nervous system? Clin Neurophysiol Pract. 2018;3:1-8. https://doi.org/10.1016/j.cnp.2017.11.001
  15. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 2003 Apr;24(2):236-52. https://doi.org/10.1210/er.2002-0014

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts